BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 1721713)

  • 1. Estimating the risk of a fetal autosomal trisomy at mid-trimester using maternal serum alpha-fetoprotein and age: a retrospective study of 142 pregnancies.
    Zeitune M; Aitken DA; Crossley JA; Yates JR; Cooke A; Ferguson-Smith MA
    Prenat Diagn; 1991 Nov; 11(11):847-57. PubMed ID: 1721713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteration in age-specific risks for chromosomal trisomy by maternal serum alpha-fetoprotein and human chorionic gonadotropin screening.
    Miller CH; O'Brien TJ; Chatelain S; Butler BB; Quirk JG
    Prenat Diagn; 1991 Mar; 11(3):153-8. PubMed ID: 1710067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prenatal screening for chromosome abnormalities using maternal serum chorionic gonadotrophin, alpha-fetoprotein, and age.
    Crossley JA; Aitken DA; Connor JM
    Prenat Diagn; 1991 Feb; 11(2):83-101. PubMed ID: 1712100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal serum alpha-fetoprotein and fetal autosomal trisomies.
    Doran TA; Cadesky K; Wong PY; Mastrogiacomo C; Capello T
    Am J Obstet Gynecol; 1986 Feb; 154(2):277-81. PubMed ID: 2418684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trisomy 18 and maternal serum and amniotic fluid alpha-fetoprotein.
    Lindenbaum RH; Ryynänen M; Holmes-Siedle M; Puhakainen E; Jonasson J; Keenan J
    Prenat Diagn; 1987 Sep; 7(7):511-9. PubMed ID: 2444965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A retrospective evaluation of maternal serum screening for the detection of fetal aneuploidy.
    Suzumori K; Tanemura M; Murakami I; Okada S; Natori M; Tanaka M; Takagi T; Sato A
    Prenat Diagn; 1997 Sep; 17(9):861-6. PubMed ID: 9316131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First-trimester maternal serum alpha-fetoprotein as a marker for fetal chromosomal disorders. Dutch Working Party on Prenatal Diagnosis.
    Van Lith JM
    Prenat Diagn; 1994 Oct; 14(10):963-71. PubMed ID: 7534926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amniotic fluid alpha-fetoprotein levels during midtrimester of trisomy pregnancies.
    Hsu JJ; Hseih TT; Liou JD; Soong YK
    J Formos Med Assoc; 1994 Jun; 93(6):492-6. PubMed ID: 7532053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First-trimester alpha-fetoprotein screening for Down syndrome.
    Fuhrmann W; Altland K; Jovanovic V; Holzgreve W; Miny P; Wenger D; Rauskolb R
    Prenat Diagn; 1993 Mar; 13(3):215-8. PubMed ID: 7685089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of combining maternal serum alpha-fetoprotein and hCG in a second-trimester screening program for Down syndrome.
    Mooney RA; Peterson CJ; French CA; Saller DN; Arvan DA
    Obstet Gynecol; 1994 Aug; 84(2):298-303. PubMed ID: 7518896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First-trimester maternal serum alpha-fetoprotein and chorionic gonadotropin in aneuploid pregnancies.
    Johnson A; Cowchock FS; Darby M; Wapner R; Jackson LG
    Prenat Diagn; 1991 Jul; 11(7):443-50. PubMed ID: 1721715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second trimester maternal serum screening using alpha fetoprotein, free beta human chorionic gonadotropin and maternal age specific risk: result of chromosomal abnormalities detected in screen positive for Down syndrome in an Asian population.
    Chao AS; Chung CL; Wu CD; Chang SD; Cheng PJ; Lin YT; Soong YK
    Acta Obstet Gynecol Scand; 1999 May; 78(5):393-7. PubMed ID: 10326883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First trimester maternal serum alpha-fetoprotein in fetal trisomies.
    Brizot ML; Kuhn P; Bersinger NA; Snijders RJ; Nicolaides KH
    Br J Obstet Gynaecol; 1995 Jan; 102(1):31-4. PubMed ID: 7530490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expanding multiple marker screening for Down's syndrome to include Edward's syndrome.
    Barkai G; Goldman B; Ries L; Chaki R; Zer T; Cuckle H
    Prenat Diagn; 1993 Sep; 13(9):843-50. PubMed ID: 7506408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second trimester prenatal screening for Down's syndrome using alpha-fetoprotein and free beta hCG: a seven year review.
    Spencer K
    Br J Obstet Gynaecol; 1999 Dec; 106(12):1287-93. PubMed ID: 10609723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for fetal Down's syndrome in pregnancy by measuring maternal serum alpha-fetoprotein levels.
    DiMaio MS; Baumgarten A; Greenstein RM; Saal HM; Mahoney MJ
    N Engl J Med; 1987 Aug; 317(6):342-6. PubMed ID: 2439909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-fetoprotein in fetal serum, amniotic fluid, and maternal serum.
    Van Lith JM; Beekhuis JR; Van Loon AJ; Mantingh A; De Wolf BT; Breed AS
    Prenat Diagn; 1991 Aug; 11(8):625-8. PubMed ID: 1722580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
    McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
    J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk-based prenatal screening for trisomy 18 using alpha-fetoprotein, unconjugated oestriol and human chorionic gonadotropin.
    Palomaki GE; Haddow JE; Knight GJ; Wald NJ; Kennard A; Canick JA; Saller DN; Blitzer MG; Dickerman LH; Fisher R
    Prenat Diagn; 1995 Aug; 15(8):713-23. PubMed ID: 7479589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.